Ae Wealth Management LLC Uni Qure N.V. Transaction History

Ae Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 11, 2023	BUY	$6.71 - $11.83 $181,411 - $319,835	27,036 Added 60.86%	71,461 $479,000
Q2 2023 Jul 10, 2023	BUY	$11.12 - $22.2 $494,005 - $986,235	44,425 New	44,425 $509,000
Q3 2020 Nov 06, 2020	SELL	$35.98 - $47.66 $455,075 - $602,803	-12,648 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$45.06 - $67.74 $209,213 - $314,516	4,643 Added 58.0%	12,648 $570,000
Q1 2020 May 07, 2020	BUY	$40.01 - $73.97 $320,280 - $592,129	8,005 New	8,005 $380,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ae Wealth Management LLC with notifications on news.